Early Phase 1 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged over 30 of any sex or ethnic background may be considered.
- People who have no history of open-angle glaucoma (a specific type of eye pressure condition) may be considered.
- People whose eye examination by a glaucoma specialist showed no signs of open-angle glaucoma may be considered.
- People whose specialized eye scan (a test that measures the nerve fibers at the back of the eye) came back normal may be considered.
- People who have a condition affecting the optic nerve (the nerve connecting the eye to the brain) may be considered.
- Both people suspected of having glaucoma damage and those who already have confirmed glaucoma damage may be considered.
- If both eyes meet the trial's criteria, both eyes may be included in the study.
Who may not be able to join:
- People who are unable to sit upright due to a physical disability.
- People whose eye clarity is affected by clouding, corneal scarring, cataracts, or bleeding inside the eye that would prevent clear imaging.
- People who are unable to keep their eyes open comfortably during the imaging procedure.
- People who are unable to accurately perform eye pressure measurements at home during the practice/certification stage.
- People whose specialized eye scan (OCT) results are not considered reliable.
- People who have any form of glaucoma (confirm with trial site, as this appears to conflict with some inclusion criteria above).
- People with very high short-sightedness, defined as a prescription stronger than -8.
- People who have had laser or surgical vision correction, or have a corneal disease or abnormal corneal shape, that would make home eye pressure readings difficult to interpret.
- People who are unable to understand English, or who have a language or hearing impairment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Harry Quigley, MD, Johns Hopkins University
Phone: 410 955 6051
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Optic nerve head strain
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.